Belvederi Murri M. Prestia D. Mondelli V. Pariante C. Patti S. Olivieri B. Arzani C. Masotti M. Respino M. Antonioli M. et al.

Calkin C. van de Velde C. Ruzickova M. Slaney C. Garnham J. Hajek T. O'Donovan C. Alda M. Can body mass index help predict outcome in patients with bipolar disorder Bipolar Disord.

Kohlmann K. Jeavons S. Schapkaitz I. Anderson-Hunt M. Berk M. N-acetylcysteine for major depressive episodes in bipolar disorder.

Siwek M. Sowa-Kucma M. Styczen K. Misztak P. Nowak R.J. Szewczyk B. Dudek D. Rybakowski J.K. Nowak G. Maes M. Associations of Serum Cytokine Receptor Levels with Melancholia Staging of Illness Depressive and Manic Phases and Severity of Depression in Bipolar Disorder.

Maes M. Ringel K. Kubera M. Berk M. Rybakowski J.

Saroukhani S. Emami-Parsa M. Modabbernia A. Ashrafi M. Farokhnia M. Hajiaghaee R. Akhondzadeh S. Aspirin for treatment of lithium-associated sexual dysfunction in men Randomized double-blind placebo-controlled study.

Miyaoka T. Wake R. Furuya M. Liaury K. Ieda M. Kawakami K. Tsuchie K. Taki M. Ishihara K. Araki T. et al.

Since the first case report of minocycline for bipolar depression was published in 1996  there has been significant interest and off-label prescribing of minocycline for bipolar and unipolar depression however until this year 2017 there were no published RCTs to support or refute the antidepressant effects of minocycline.

Jr. Metabolic syndrome in bipolar disorder A review with a focus on bipolar depression.

Double-blind randomized placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

